copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Prostate-specific antigen (PSA) levels by age: What to know What constitutes a normal prostate-specific antigen (PSA) level? Why might someone’s PSA levels be elevated? And, is there such a thing as a “dangerously high” PSA level? Urologic surgeon Lisly Chéry, M D , weighs in on these and three other frequently asked questions
Prostate-Specific Antigen (PSA) Test - NCI Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland Both prostate cancer and several benign conditions (particularly benign prostatic hyperplasia, or BPH, and prostatitis) can cause PSA levels in the blood to rise The PSA test measures the level of PSA in the blood This test is used in several different ways: to monitor the
Normal PSA Levels by Age Chart: What You Need to Know About . . . Understanding Your Numbers: A Visual PSA Guide Let’s make these PSA numbers crystal clear The chart below shows what doctors consider normal, borderline, and high PSA levels for each age group Think of it as your personal PSA roadmap The measurements are in nanograms per milliliter (ng mL), the standard way doctors measure PSA in your blood Each age group has different normal ranges
Normal PSA Levels by Age: Understanding Your Prostate Health . . . Normal Results: If your PSA level falls comfortably within the normal range for your age group, celebrate this good news and continue with regular annual screening Use this time to maintain those healthy lifestyle choices and stay aware of any new symptoms
PSA Levels by Age: Whats Normal, 12 Symptoms of High PSA . . . For men in their 40s and 50s a PSA greater than 2 5 ng ml is considered too high and for men in their 60s a PSA greater than 4 0 ng ml is considered too high Generally, the higher a man’s PSA level, the greater his risk of having prostate cancer